Effect of aerosolized antibiotics on proinflammatory cytokines Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002
Effect of hypertonic and isotonic saline inhalation on inflammatory cells, granulocyte mediators and chemokines in induced sputum of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 792s Year: 2006
Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015
Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD Source: Eur Respir J 2007; 30: Suppl. 51, 141s Year: 2007
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012
Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002
The interrelationship of the inflammatory markers in blood and sputum of stable COPD patients before and after treatment with inhaled steroids and N-acetylcysteine Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003
Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
Immunological mechanisms of intravenous roncoleucin (IL-2) clinical effects in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 512s Year: 2002
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019
In COPD moxifloxacin enhances th1-immune response in the presence of bacterial endotoxin by inducing IL-2 expression Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
Expression of inflammatory cytokines following stepwise dose reduction of corticosteroids of long-term oral corticosteroids users with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004
Eotaxin-2 in sputum cell culture to evaluate asthma inflammation Source: Eur Respir J 2007; 29: 489-495 Year: 2007
The effect of inhaled corticosteroids on bronchoalveolar lavage interleukin-8 levels and cell percentage in stable chronic obstructive pulmonary disease patients Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001
Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019